42 results about "Increase blood pressure" patented technology

In one embodiment, the invention provides a medical method for treating a person and comprises repeatedly compressing the person's chest. While repeatedly compressing the person's chest, the method further includes repeatedly delivering a positive pressure breath to the person and extracting respiratory gases from the person's airway using a vacuum following the positive pressure breath to create an intrathoracic vacuum to lower pressures in the thorax and to enhance blood flow back to the heart.

The invention provides a method and system for transiently occluding a vein that is downstream of an organ such as the brain, where the occlusion increases blood pressure within the vein, and where the increased pressure stimulates a reflex that reduces entry of emboli into that organ.

Methods for treating or preventing cardiomyopathy in a subject by administering an al adrenergic receptor agonist, wherein the treatment does not result in increased blood pressure are provided.

The invention provides a drug recommendation method, device and server based on literature data. The method includes the steps that abstract data of all articles in a biomedicine literature database is obtained; an abstract database of articles related to a certain special people group with hypertension is set up by limiting medical subject headings; data indexes for evaluating quality of the articles related to the certain special people group with hypertension are set up; the article, author, periodical and print type in all the articles related to the certain special people group with hypertension and information of various kinds of antihypertensive drugs are extracted according to the abstract database; weighted isomerism graphs are constructed according to the extracted information and the data indexes; the weighted isomerism graphs are sorted, and ranking information of the antihypertensive drugs suitable for the certain special people group with hypertension is obtained. The method can recommend ranking information of the antihypertensive drugs suitable for the various special people groups to improve the cognition degree to use conditions of the antihypertensive drugs of grass-roots doctors, increase blood pressure rate of reaching the standard and improve the current situation of poor control over hypertension.

The invention relates to a low-sugar wafer biscuit and belongs to the technical field of food processing. The low-sugar wafer biscuit mainly contains flour, corn starch, stevia extract, medlar powder, peanut meal, whole milk powder, olive oil, salt, swelling agent and the like. The low-sugar wafer biscuit is rich of protein, does not contain sucrose, does not increase blood pressure, blood glucose and blood fat after being eaten for a long period of time and is suitable for various populations.

The invention relates to a blood-pressure-treating traditional Chinese medicine composition, and specifically relates to a nerve-soothing blood-pressure-reducing traditional Chinese medicine tea. The invention provides the tea aiming at solving a series of health problems caused by increased blood pressure due to higher mental dysfunction caused by fast life pace, increased work pressure, and inappropriate diet and rest. The nerve-soothing blood-pressure-reducing traditional Chinese medicine tea is composed of the raw materials, by weight: 30-120 parts of mulberry leaves, 25-125 parts of hawthorn leaves, 20-100 parts of eucommia leaves, 20-100 parts of Japanese pogodatree flower, 15-75 parts of white chrysanthemum, 10-50 parts of Szechwan lovage rhizome, 10-50 parts of obtuseleaf senna seed, and 10-50 parts of ginkgo leaves. When the nerve-soothing blood-pressure-reducing tea provided by the invention is taken for a long time, human body functioning can be gradually improved. The tea has the functions of human central nervou regulating, fatigue relieving, sleep promoting, body immunity enhancing, human body self-regulation enhancing, and blood pressure fluctuation suppressing.

Methods and devices are presented which act by cutting the renal nerves slowly through. The minimally invasive implantable devices can be delivered through state of the art delivery catheters into the renal arteries as known from stenting, and do not require external generators, thereby being easily to introduce in normal equipped radiology catheter labs.

The present invention discloses devices, systems and methods for increasing blood pressure in a blood vessel by introducing an anchor within that traps a particle capable of increasing in volume as it is exposed to blood flow. As the particle increases in volume, it serves to decrease the cross sectional area of the blood vessel, resulting in decreased blood flow and increased blood pressure. This invention may be used to arterialize blood vessels in the venous system to prepare them for an exposure to arterial pressures.

Circulating levels of catestatin (Cts: human chromogranin A352-372) decrease in the plasma of patients with essential hypertension. Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pre-treatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension. This notable vasoreactivity prompted us to test the direct cardiovascular effects and mechanisms of action of wild-type Cts (WT-Cts) and naturally occurring human variants (G364S-Cts and P370L-Cts) on myocardial and coronary functions. The cardio-inhibitory influence exerted on basal mechanical performance and the counter-regulatory action against beta-adrenergic and ET-1 stimulations, point to Cts as a novel cardiac modulator, able to protect the heart against excessive sympathochromaffin over-activation, e.g. hypertensive cardiomyopathy.

The present invention is aimed at providing an opioid antagonist compound and preparation method thereof, and its medical use. The medical use for opioid antagonists such as the compound of formula (I) (shown below) include complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, such as heroin, fentanyl, oxycodone, hydrocodone, morphine, propoxyphene, methadone and certain narcotic-antagonist analgesics, such as nalbuphine, pentazocine and butorphanol. An opioid antagonist may also be useful as an adjunctive agent to increase blood pressure in the management of septic shock. Further, opioid antagonists also have been shown to reduce the craving for alcohol.

The invention discloses hydrogenated cortisone derivant from NO as compound I in the medical chemical domain, which reserves or reinforces anti-inflammatory action and lessens the bad reaction of elevation of blood pressure and osteoporosis.

The invention provides a preparation method of unpolished rice-buckwheat mixed nutrition porridge. The unpolished rice is used so as to improve nutritional compositions of the grains. The preparation method of the unpolished rice-buckwheat mixed nutrition porridge comprises the following steps: pre-treating the unpolished rice, namely freezing the unpolished rice at 5 DEG C below zero so as to cause a small amount of damages to the unpolished rice grains, so that bee-ball-shaped small holes are formed on the unpolished rice grains; and then, treating the pre-treated unpolished rice in a treatment solution which has been prepared in advance, so that the unpolished rice grains are infiltrated by active ingredients of the treatment solution, and the nutritive values of the unpolished rice are thereby improved. The treatment solution prepared in advance is prepared from the following main ingredients: bananas, lemons and paper mulberry fruits; the bananas and the lemons are common fruits; the bananas are rich in potassium and magnesium contents, wherein the potassium is capable of preventing increased blood pressure and muscle spasm, and the magnesium has the effect of relieving fatigue; the lemons are rich in citric acid and vitamin C contents; and the paper mulberry fruits can be directly eaten or used as a traditional Chinese medicine after treatment, and have good effects of reinforcing the bones and muscles, as well as sterilizing. The mixed use of the bananas, the lemons and the paper mulberry fruits has obvious effects of improving movement functions of the people who exercise regularly.

Particular aspects of the present invention provide pharmaceutical compositions comprising isoprenoid-based compounds (e.g., farnesol and/or farnesol analogues or derivatives) or dehydroisoprenoid-based compounds, and novel methods for using same in treating (e.g., suppressing): alcohol withdrawal syndrome and associated neurological symptoms (e.g., depression, tremor, anxiety, autonomic hyperactivity (e.g., sweating, increased blood pressure, tachycardia), hallucinations, alcohol withdrawal seizures, delirium tremens (DT), and memory loss); or for treating in treating convulsive seizure (e.g., epileptic seizure, etc.). Particular pharmaceutical compositions and methods comprise the use of at least one compound selected from the group consisting of: (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol (all-trans farnesol); (2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol (cis-farnesol); (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol nerolidol); (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-amine (farnesylamine); (E)-3-(3,7-dimethylocta-2,6-dienyloxy)phenol (geranylresorcinol); (2E,6E)-,7,11-dimethyl-3-(trifluoromethyl)dodeca-2,6,10-trien-1-ol (trifluorofarnesol); and (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraen-1-ol (all-trans retinol). According to additional aspects, compounds that target and inhibit enzymes that degrade/metabolize/inactivate the disclosed compounds have utility to induce endogenous accumulation thereof to suppress/prevent, e.g., alcohol withdrawal seizures or convulsive seizures.

The invention relates to a pharmaceutical composition for treating hypotension, and belongs to the technical field of traditional Chinese medicine. The pharmaceutical composition consists of the following traditional Chinese medicinal materials in parts by weight: 10-20 parts of radix angelicae sinensis, 20-35 parts of radix codonopsis, 20-40 parts of radix astragali, 10-30 parts of rhizoma ligustici wallichii, 10-15 parts of radix aconiti carmichaeli, 8-12 parts of cassia twig, 10-15 parts of white atractylodes rhizome, 10-15 parts of dried orange peel, 10-15 parts of radix bupleuri, 15-20 parts of radix glycyrrhizae preparata and 10-20 parts of rhizoma cimicifugae. The pharmaceutical composition for treating hypotension disclosed by the invention is scientific in compatibility and easily available in raw material; the pharmaceutical composition is capable of warming and activating yang, tonifying spleen and invigorating spleen, and the pharmaceutical composition is conducive to the improvement of the excitability of a central nervous system and is capable of improving vasomotor center functions; the pharmaceutical composition is beneficial for increasing blood pressure and improving clinical symptoms; and the pharmaceutical composition is significant and reliable in efficacy and is free from side effects.

Compounds, compositions and methods are provided for mitochondrial modulation. The subject mitochondrial modulator compounds generally include a head group linked to a charged moiety. In certain cases, the head group is a heterocyclic or a heteroaryl group. Aspects of the subject methods include a method of modulating mitochondria. Aspects of the subject methods include treating a subject having a metabolic syndrome-related disease or a symptom thereof by administering to the subject a therapeutically effective amount of a subject compound. In certain cases, the disease is selected from hyperlipidemia, type 2 diabetes, fatty liver disease, obesity, cardiovascular disease and stroke. In certain cases, the symptom is selected from abdominal obesity, insulin resistance, hyperinsulinemia, high levels of blood fats, increased blood pressure, and elevated serum lipids.

The invention discloses novel liquid medicine capable of treating cancer and having many other effects. The novel liquid medicine is prepared by using disodium hydrogen phosphate, carbonized hair andwater according to a certain proportion. The novel liquid medicine has the advantages that the new liquid medicine can be intermittently taken by cancer patients for a long time to treat cancer and prevent massive hemorrhage caused by tissue wounds formed after the cancer is dissolved, can be taken by patients with diabetes type I to inhibit the complication of the diabetes type I, can be taken bypatients with diabetes type II to lower blood sugar concentration, can be taken by hypertension patients to lower blood pressure, can be taken by hypotension patients to increase blood pressure, canbe taken by patients who have a cold to inhibit cold viruses, can be taken by patients with in-vivo herpes viruses and hepatitis B viruses to inhibit the herpes viruses and hepatitis B viruses, and can treat various other chronic diseases; the novel liquid medicine can also be intermittently taken by common people to achieve a healthcare effect, and the people who take the liquid medicine can havephysical and psychological health and pleasure and can be rejuvenated; the people who begin taking the liquid medicine need to be guided by staff with professional knowledge and skills and can take the liquid medicine by themselves after they master the main points; the effective liquid medicine is prepared on the basis of the scientific theoretical knowledge of the inventor and through constantmassive interest observation, logical highly-initiative analysis, judgment and reasoning, self-trial and trials on other people and constant improvement by the inventor, and the novel liquid medicineis an updated and original invention of the inventor.

The invention relates to donkey-hide gelatin plasma substitute and a preparation method thereof. The donkey-hide gelatin plasma substitute is an injection, and donkey-hide gelatin in the donkey-hide gelatin plasma substitute has a molecular weight below 18,000. Through action of biological enzyme, macromolecular gelatin molecules in donkey-hide gelatin are subjected to chemical cutting, so that molecular weight of active ingredients of the donkey-hide gelatin is kept below 18,000, and molecules of the donkey-hide gelatin in the range are faster in a filtering process, so that filtering efficiency is improved, and allergic reaction is eliminated; In addition, transparency and clarity of a solution in the finally prepared injection are improved, and particles and impurities do not exist. In addition, through more than two thousands of repeated animal experiments, namely clinical research, no toxic and side effects, allergic reaction or three carcinogenic toxicity are found. Moreover, the donkey-hide gelatin plasma substitute is safe and effective, and can improve microcirculation, increase blood volume and rapidly increase blood pressure.